Heat Biologics (HTBX) Subsidiary Pelican Therapeutics Reports Manufacturing Agreement with KBI Biopharma to Advance Cancer-Targeting Immunotherapies
Tweet Send to a Friend
Pelican Therapeutics ("Pelican"), a subsidiary of Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), entered into a manufacturing agreement with KBI Biopharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
